Related references
Note: Only part of the references are listed.Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
Arun J. Sanyal et al.
HEPATOLOGY (2022)
The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression
Guangyan Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)
Single-Cell, Single-Nucleus, and Spatial RNA Sequencing of the Human Liver Identifies Cholangiocyte and Mesenchymal Heterogeneity
Tallulah S. Andrews et al.
HEPATOLOGY COMMUNICATIONS (2022)
Immune cell-mediated features of non-alcoholic steatohepatitis
Thierry Huby et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis
Changyu Zhu et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent
Ivana Semova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019
Pegah Golabi et al.
JOURNAL OF HEPATOLOGY (2021)
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Inference and analysis of cell-cell communication using CellChat
Suoqin Jin et al.
NATURE COMMUNICATIONS (2021)
Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication
Anne Loft et al.
CELL METABOLISM (2021)
Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids
Wenxiang Hu et al.
CELL METABOLISM (2021)
New drugs for NASH
Somaya A. M. Albhaisi et al.
LIVER INTERNATIONAL (2021)
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Aleksandra Deczkowska et al.
NATURE MEDICINE (2021)
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis
Junjie Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis
Jason S. Seidman et al.
IMMUNITY (2020)
Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-α Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury
Alexander Kikuchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
Henrik H. Hansen et al.
BMC GASTROENTEROLOGY (2020)
The hepatocyte clock and feeding control chronophysiology of multiple liver cell types
Dongyin Guan et al.
SCIENCE (2020)
The role of IFN in the development of NAFLD and NASH
Michelle Mohlenberg et al.
CYTOKINE (2019)
Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances
Keisaku Sato et al.
HEPATOLOGY (2019)
Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease
Adel Hammoutene et al.
JOURNAL OF HEPATOLOGY (2019)
Characterization of Vitamin A Metabolome in Human Livers With and Without Nonalcoholic Fatty Liver Disease
Guo Zhong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
Xuelian Xiong et al.
MOLECULAR CELL (2019)
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
P. Ramachandran et al.
NATURE (2019)
Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease
Stephen A. Hoang et al.
SCIENTIFIC REPORTS (2019)
Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis
Ross Dobie et al.
CELL REPORTS (2019)
Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi
Xuelian Xiong et al.
MOLECULAR METABOLISM (2019)
Adipose type I interferon signalling protects against metabolic dysfunction
Verena Wieser et al.
GUT (2018)
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Silvana Konermann et al.
CELL (2018)
EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
Patrice N. Mimche et al.
SCIENTIFIC REPORTS (2018)
Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes
Dongyin Guan et al.
CELL (2018)
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Marcus Grohmann et al.
CELL (2018)
Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice
Xianjun Luo et al.
GASTROENTEROLOGY (2018)
Therapeutic potential of targeting the Eph/ephrin signaling complex
Nayanendu Saha et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Changyu Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
Sonya A. MacParland et al.
NATURE COMMUNICATIONS (2018)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
Keren Bahar Halpern et al.
NATURE (2017)
Single-cell mRNA quantification and differential analysis with Census
Xiaojie Qiu et al.
NATURE METHODS (2017)
Cellular senescence drives age-dependent hepatic steatosis
Mikolaj Ogrodnik et al.
NATURE COMMUNICATIONS (2017)
Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome
Magar Ghazarian et al.
SCIENCE IMMUNOLOGY (2017)
CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy
Xiang Zhang et al.
JOURNAL OF HEPATOLOGY (2016)
Mechanisms of ephrin-Eph signalling in development, physiology and disease
Artur Kania et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice
Patrice N. Mimche et al.
HEPATOLOGY (2015)
Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis
Jamie E. Mells et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Investigation of the interactions between the EphB2 receptor and SNEW peptide variants
Buyong Ma et al.
GROWTH FACTORS (2014)
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
Xiang Zhang et al.
JOURNAL OF HEPATOLOGY (2014)
Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer
Weifan Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Robust cellular reprogramming occurs spontaneously during liver regeneration
Kilangsungla Yanger et al.
GENES & DEVELOPMENT (2013)
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
Masahiko Matsumoto et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Inflammatory Mechanisms in Obesity
Margaret F. Gregor et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Hepatocyte growth factor twenty years on: Much more than a growth factor
Takahiro Nakamura et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Hermann E. Wasmuth et al.
GASTROENTEROLOGY (2009)
GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking
CC Hoogenraad et al.
NATURE NEUROSCIENCE (2005)
EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer
WG Mao et al.
CANCER RESEARCH (2004)
Viruses and interferon: A fight for supremacy
MG Katze et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Share Paper
